Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study

By afschroeder • July 6, 2025

Aggarwal R, Schessl J, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis CV, Schiopu E, Vencovský J, Clodi E, Levine T, Charles-Schoeman C; ProDERM investigators. Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study. Rheumatol Ther. 2025 Jul 5. doi: 10.1007/s40744-025-00775-5. Epub ahead of print. PMID: 40616720.

Tags: Arthralgia, Arthritis, Constitutional, Dermatomyositis, gastrointestinal, Immunoglobulins, Intravenous, Octagam, Publications, pulmonary, Rheumatology, Skeletal

Pragmatic Comparative Effectiveness Trials in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multiperspective Qualitative Study

Kaczorowski-Worthley A, Mudaranthakam DP, Reichuber J, Streiler C, Pandya S, Boente R, Mathai SK, Adegunsoye A, Swigris J, Volkmann ER, Solomon JJ, England BR, Matson[...]

Reduced-dose vs full-dose direct oral anticoagulants for extended treatment of venous thromboembolism: a meta-analysis of randomized controlled trials

Ahmed M, Zulfiqar E, Ashraf H, Hashmi TM, Ahmed R, Rana JS, Greene SJ, Mentz RJ, Fudim M, Fonarow GC. Reduced-dose vs full-dose direct oral[...]

Provider Attitudes and Perceptions on Using Artificial Intelligence in Colonoscopy: A Systematic Review and Meta-Analysis

Soleymanjahi S, Rajashekar N, Chung S, Grimshaw AA, Tvedt MJK, Foroutan F, Sultan S, Shung DL, Kolb JM. Provider Attitudes and Perceptions on Using Artificial[...]